Lewis Nelson, MD

The FDA on Wednesday approved 4 mg Narcan nasal spray for over-the-counter use as an emergency treatment for opioid overdose. It is the first naloxone product to be available without a prescription.

The CDC has released updated and expanded clinical practice guidance on prescribing opioids to patients with short- and long-term pain.

High psychological distress, including anxiety, worry and depression, before SARS-CoV-2 infection may be a risk factor for developing post-COVID-19 symptoms, a recent study published in JAMA Psychiatry found.

Senators have announced a bipartisan proposal to reduce the threat of gun violence in the United States.

For the first time, provisional data from the CDC showed that more than 100,000 people in the United States died from drug overdoses in a 12-month period.

Provisional data from the CDC revealed a 1.5-year decline in life expectancy in the United States from 2019 to 2020.

One-fifth of older patients discharged with gabapentin following a surgical procedure had the prescription refilled for more than 90 days, suggesting long-term use is common, according to an analysis of Medicare data.

Patients with migraine who were given opioids in the ED were more likely to return to the ED in the next 6 months compared with patients who were not prescribed opioids, according to findings from single-center, retrospective cohort study.

A collaborative care model that utilizes buprenorphine-waivered physicians and community pharmacists was associated with high rates of opioid use disorder treatment retention and adherence, results of a pilot study showed.

Purdue Pharma and the United States Department of Justice announced that they have reached a deal that resolves multiyear civil and criminal investigations into the pharmaceutical company’s marketing practices related to its opioid medications.